IMNM
Immunome Inc
3월 13일 4:00 PM ET (한국 3/14 05:00)
$20.36
-0.63 ▼ -3.00%
🌙 3월 13일 5:21 PM ET (한국 3/14 06:21)
$20.39
+0.03 ▲ +0.15%
| Index | RUT | P/E | - | EPS (ttm) | -2.43 | Insider Own | 9.55% | Shs Outstand | 0.11B | Perf Week | -3.23% |
| Market Cap | 2.30B | Forward P/E | - | EPS next Y | 7.56% | Insider Trans | -2.81% | Shs Float | 0.10B | Perf Month | -13.03% |
| Enterprise Value | 1.65B | PEG | - | EPS next Q | -0.55 | Inst Own | 99.02% | Short Float | 17.48% | Perf Quarter | 0.3% |
| Income | -0.21B | P/S | 331.9 | EPS this Y | 1.03% | Inst Trans | 25.7% | Short Ratio | 8.56 | Perf Half Y | 110.33% |
| Sales | 0.01B | P/B | 3.63 | EPS next 5Y | 24.04% | ROA | -46% | Short Interest | 17.89M | Perf YTD | -5.21% |
| Book/sh | 5.61 | P/C | 3.52 | EPS past 3/5Y | 7.72% -7.71% | ROE | -52.09% | 52W High | -26.37% ($27.65) | Perf Year | 128% |
| Cash/sh | 5.78 | P/FCF | - | Sales past 3/5Y | - | ROIC | -33.28% | 52W Low | 295.33% ($5.15) | Perf 3Y | 382.46% |
| Dividend Est. | - | EV/EBITDA | - | EPS Y/Y TTM | 53.1% | Gross Margin | 57.43% | Volatility(W/M) | 6.05% 5.5% | Perf 5Y | -30.27% |
| Dividend TTM | - | EV/Sales | 238.29 | Sales Y/Y TTM | -23.23% | Oper. Margin | -3084.76% | ATR (14) | 1.3 | Perf 10Y | - |
| Dividend Ex-Date | - | Quick Ratio | 14.69 | EPS Q/Q | 41.27% | Profit Margin | -3059.99% | RSI (14) | 38.67 | Recom | 1 |
| Dividend Gr. 3/5Y | - | Current Ratio | 14.69 | Sales Q/Q | -100% | SMA20 | -6.28% ($21.72) | Beta | 2.19 | Target Price | $35.54 |
| Payout | - | Debt/Eq | 0.01 | Earnings | 3000000 | SMA50 | -10.24% ($22.68) | Rel Volume | 0.47 | Prev Close | $20.99 |
| Employees | 177 | LT Debt/Eq | 0.01 | EPS/Sales Surpr. | -28.77% -100% | SMA200 | 32.16% ($15.41) | Avg Volume(3M) | 2.09M | Price | $20.36 |
| IPO | 2020/10/2 | Option/Short | Yes/Yes | Trades | 9544 | Volume | 983,594 | Change | -3% |
뉴스 로딩 중...